Go Pro
CVE:EBN

Epicore BioNetworks (EBN) Stock Price, News & Analysis

C$1.29 -0.01 (-0.77%)
As of 12/14/2017

About Epicore BioNetworks Stock (CVE:EBN)

Key Stats

Today's Range
C$1.29
C$1.29
50-Day Range
C$1.29
C$1.29
52-Week Range
C$0.54
C$1.32
Volume
54,778 shs
Average Volume
29,654 shs
Market Capitalization
C$34.03 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Epicore BioNetworks Inc. (Epicore) develops, manufactures and markets specialty biotechnology, biochemical and nutrition products. Epicore specialty biochemical products are mixtures of specialty organic, inorganic and biochemical ingredients that facilitate microbe and plant growth. Some Epicore products (such as its EPIZYM-AGP COMPLETE) stimulate algae growth, an important property in shrimp and bivalve hatcheries that grow algae as animal food. Some of its products (such as EPIZYM-BGM) support microbe growth for customers who grow-up an Epicore microbial ecosystem at their location. Some Epicore biochemical products stimulate plant growth to increase plant yield and environmental stress resistance. The third Epicore product group is specialty animal feeds. These products are an extension of its microbial growth media expertise and are primarily used in aquaculture. Its EPIFEED -LHF and EPILITE liquid shrimp larval feeds are tools to help hatchery managers raise postlarval shrimp.

Receive EBN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Epicore BioNetworks and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EBN Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

EBN Stock Analysis - Frequently Asked Questions

Epicore BioNetworks' stock was trading at C$1.29 at the start of the year. Since then, EBN stock has increased by 0.0% and is now trading at C$1.29.

Shares of EBN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Food Products
Sub-Industry
Agricultural Products & Services
Current Symbol
CVE:EBN
CIK
N/A
Fax
N/A
Employees
147,000
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
26,380,000
Free Float
N/A
Market Cap
C$34.03 million
Optionable
Not Optionable
Beta
N/A
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (CVE:EBN) was last updated on 8/12/2026 by MarketBeat.com Staff.
From Our Partners